Robert F. Kennedy Jr. & Pfizer
11 shared events · Importance 3 · Last updated Sep 03, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Tech
Robert F. Kennedy Jr.: Robert F. Kennedy Jr., as the U.S. Health and Human Services Secretary, has announced an initiative to combat Lyme disease and expressed personal commitment to finding a vaccine or treatment. His endorsement, if the vaccine is approved, could significantly influence public acceptance, especially among vaccine-skeptical groups.
Pfizer: Pfizer is a pharmaceutical company developing a new Lyme disease vaccine, which has shown 70-75% effectiveness in late-stage studies. The company plans to seek regulatory approval, which could significantly boost its market position in infectious disease prevention.
Apr 30, 2026 · 24 articles
Regulatory
Robert F. Kennedy Jr.: Kennedy's skepticism of mRNA vaccines influenced funding cuts and regulatory scrutiny, but the approval proceeded despite his opposition.
Pfizer: Pfizer, a rival in mRNA vaccines, may face competitive pressure as Moderna expands its mRNA platform into flu.
Aug 05, 2026 · 105 articles
Domestic
Robert F. Kennedy Jr.: As HHS Secretary, associated with the administration's vaccine policy changes.
Pfizer: Offers COVID-19 vaccines; benefits from continued recommendations and potential increased uptake.
Sep 02, 2026 · 20 articles
Domestic
Robert F. Kennedy Jr.: Robert F. Kennedy Jr., as Health Secretary, spearheaded changes to the United States — Centers for Disease Control and Prevention's vaccine schedule, removing recommendations for COVID-19 and flu vaccines for pregnant individuals, which has been met with strong opposition and legal action from medical groups.
Pfizer: Pfizer's Abrysvo is mentioned as the only approved RSV vaccine for use in pregnancy, indicating its market position in this specific vaccine category.
Jun 10, 2026 · 6 articles
Domestic
Robert F. Kennedy Jr.: As HHS Secretary, he has criticized vaccines and changed CDC recommendations; his actions are part of the broader context.
Pfizer: One of the vaccine manufacturers; the controversy may slightly affect public perception, but no direct impact.
Aug 06, 2026 · 17 articles
Tech
Robert F. Kennedy Jr.: As U.S. Health Secretary, Kennedy has criticized mRNA vaccines and cut $500 million in related projects, which could hinder the vaccine's approval and rollout. His actions are a potential obstacle to the therapy's success.
Pfizer: Pfizer, a partner of BioNTech, may benefit indirectly from the validation of mRNA technology in cancer treatment.
Aug 19, 2026 · 126 articles
Domestic
Robert F. Kennedy Jr.: US Health Secretary Kennedy has advocated for the CDC to stop recommending COVID-19 shots for children, citing lack of evidence of benefit.
Pfizer: Pfizer's COVID-19 vaccine (with BioNTech) may see reduced demand in Germany; the company has faced scrutiny over adverse event data.
Jul 13, 2026 · 6 articles
Domestic
Robert F. Kennedy Jr.: Health Secretary Robert F. Kennedy Jr was cited by Senator Warren as admitting that TrumpRx does not store patient information, undermining savings claims.
Pfizer: Pfizer was among the earlier 17 drugmakers that signed MFN deals, setting a precedent. The new agreements expand the framework to more companies.
Aug 18, 2026 · 37 articles
Accidents
Robert F. Kennedy Jr.: Robert F. Kennedy Jr., as Trump's health secretary, stated he was working to restore the United States — Centers for Disease Control and Prevention's focus, despite the administration's actions that weakened the agency.
Pfizer: Pfizer is mentioned in false conspiracy theories linking its vaccine to the Hantavirus outbreak, which health officials are working to counter.
May 07, 2026 · 368 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how Robert F. Kennedy Jr. and Pfizer interact across events, view sentiment trends, and discover connected entities.
Open Dashboard